FMoc-Val-Cit-PAB-MMAE
Fmoc-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate containing a cleavable Val-Cit peptide, a PABC linker and a MMAE payload. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells.
| Catalog Number | INT1350456562 |
| Alternative Name(s) | Fmoc-Val-Cit-PABC-MMAE;Fmoc-VC-PAB-MMAE;N-[[[4-[[N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide;Drug-Linker Conjugates for ADC,inhibit,FmocValCitPABMMAE,Inhibitor,Fmoc Val Cit PAB MMAE |
| Research Area | Intermediates |
| Molecular Formula | C73H104N10O14 |
| CAS# | 1350456-56-2 |
| Purity | 0.97% |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/fmoc-val-cit-pab-mmae-item-7136.html |